Skip links

Austedo® (deutetrabenazine)

Full Name Austedo® (deutetrabenazine)
Drug Austedo
Manufacturer Teva Neuroscience, Inc.
Route of Administration Oral
Site of Care Home
Approved Indication Indicated in adults for the treatment of Chorea associated with Huntington’s disease and tardive dyskinesia
Disease Tardive Dyskinesia (TD); Huntington’s Disease Chorea
Therapeutic Area Psychiatry, Neurology
Enrollment Form Link Enrollment Form
Phone Number 800-691-0718
Fax Number 877-819-2424
Product Website